Altered responses to pneumococcal vaccination in an elderly diabetic Japanese vaccine trial: The risk of concurrent vaccination strategies

被引：1
作者：
Norton, Elizabeth B. [1 ]
机构：
[1] Tulane Univ, Sch Med, Dept Microbiol & Immunol, 1430 Tulane Ave 8638, New Orleans, LA 70112 USA
来源：
JOURNAL OF DIABETES AND ITS COMPLICATIONS | 2019年 / 33卷 / 03期
关键词：
POLYSACCHARIDE VACCINE; PNEUMONIA; ADULTS; COMMUNITY; INFLUENZA; SAFETY;
D O I：
10.1016/j.jdiacomp.2018.12.007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：189 / 190
页数：2
相关论文
共 41 条
  • [21] Relationship between public subsidies and vaccination rates with the 23-valent pneumococcal vaccine in elderly persons, including the influence of the free vaccination campaign after the Great East Japan Earthquake
    Naito, Toshio
    Matsuda, Naoto
    Tanei, Mika
    Watanabe, Yukiko
    Watanabe, Akira
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2014, 20 (7-8) : 450 - 453
  • [22] Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers
    Iorio, A. M.
    Camilloni, B.
    Basileo, M.
    Neri, M.
    Lepri, E.
    Spighi, M.
    GERONTOLOGY, 2007, 53 (06) : 411 - 418
  • [23] Altered immunogenicity of 23-valent pneumococcal polysaccharide vaccine in elderly patients with diabetes who revealed lower responses to concomitant administration of BIKEN varicella zoster vaccine: Results of post hoc analysis of a randomized double-blind trial
    Hata, Atsuko
    Ishioka, Taisei
    Oishi, Kazunori
    Katayama, Toshiro
    Ohkubo, Takayoshi
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2019, 33 (03) : 243 - 248
  • [24] Immunological Efficacy of Pneumococcal Vaccination Including the 13-Valent Pneumococcal Conjugate Vaccine in Adult Patients With Sickle Cell Disease: Results of the Randomized DREVAC Controlled Trial
    Melica, Giovanna
    Bartolucci, Pablo
    Audureau, Etienne
    Le Corvoisier, Philippe
    Habibi, Anoosha
    Gellen, Justine
    Selmane, Dalia
    Michel, Marc
    Lacabaratz, Christine
    Levy, Yves
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (11) : 1949 - 1958
  • [25] Comparison of serologic responses to vaccination with one dose or two doses of 7-valent pneumococcal conjugate vaccine in HIV-infected adult patients
    Lu, Ching-Lan
    Hung, Chien-Ching
    Chuang, Yu-Chung
    Liu, Wen-Chun
    Su, Chun-Ting
    Hsiao, Chin-Fu
    Tseng, Yu-Tzu
    Su, Yi-Ching
    Chang, Shu-Fang
    Chang, Sui-Yuan
    Chang, Shan-Chwen
    VACCINE, 2012, 30 (24) : 3526 - 3533
  • [26] Quantitative and Qualitative Anamnestic Immune Responses to Pneumococcal Conjugate Vaccine in HIV-Infected and HIV-Uninfected Children 5 Years after Vaccination
    Madhi, Shabir A.
    Klugman, Keith P.
    Kuwanda, Locadiah
    Cutland, Clare
    Kaeyhty, Helena
    Adrian, Peter
    JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (08) : 1168 - 1176
  • [27] Pneumococcal vaccine schedules (PVS) study: a cluster-randomised, non-inferiority trial of an alternative versus standard schedule for pneumococcal conjugate vaccination-statistical analysis plan
    Mackenzie, Grant A. A.
    Palmu, Arto A. A.
    Jokinen, Jukka
    Osei, Isaac
    Flasche, Stefan
    Greenwood, Brian
    Mulholland, Kim
    Nguyen, Cattram
    TRIALS, 2022, 23 (01)
  • [28] Can two different pneumococcal conjugate vaccines be used to complete the infant vaccination series? A randomized trial exploring interchangeability of the 13-valent pneumococcal conjugate vaccine and the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine
    de los Santos, Abiel Mascarenas
    Rodriguez-Weber, Miguel Angel
    Sanchez-Marquez, Pedro
    Traskine, Magali
    Carreno-Manjarrez, Roberto
    Cervantes-Apolinar, Maria Yolanda
    Strezova, Ana
    Ruiz-Guinazu, Javier
    Ortega-Barria, Eduardo
    Borys, Dorota
    EXPERT REVIEW OF VACCINES, 2020, 19 (11) : 995 - 1010
  • [29] Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of pneumococcal disease: a review of the literature
    Cripps, Allan W.
    Folaranmi, Temitope
    Johnson, Kelly D.
    Musey, Luwy
    Niederman, Michael S.
    Buchwald, Ulrike K.
    EXPERT REVIEW OF VACCINES, 2021, 20 (03) : 257 - 267
  • [30] The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly Exploratory analysis of the CAPiTA trial
    Huijts, S. M.
    Coenjaerts, F. E. J.
    Bolkenbaas, M.
    van Werkhoven, C. H.
    Grobbee, D. E.
    Bonten, M. J. M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (07) : 764 - 770
12345